ATE488253T1 - Verfahren zum nachweis eines fibringerinnsels - Google Patents

Verfahren zum nachweis eines fibringerinnsels

Info

Publication number
ATE488253T1
ATE488253T1 AT98934690T AT98934690T ATE488253T1 AT E488253 T1 ATE488253 T1 AT E488253T1 AT 98934690 T AT98934690 T AT 98934690T AT 98934690 T AT98934690 T AT 98934690T AT E488253 T1 ATE488253 T1 AT E488253T1
Authority
AT
Austria
Prior art keywords
detecting
source
particles
fibring
clot
Prior art date
Application number
AT98934690T
Other languages
English (en)
Inventor
Chenicheri Nair
Elena Shats
William Burch
Rodney Browitt
Timothy Senden
Original Assignee
Univ Australian
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Australian filed Critical Univ Australian
Application granted granted Critical
Publication of ATE488253T1 publication Critical patent/ATE488253T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1241—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins
    • A61K51/1244—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins microparticles or nanoparticles, e.g. polymeric nanoparticles
    • A61K51/1251—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins microparticles or nanoparticles, e.g. polymeric nanoparticles micro- or nanospheres, micro- or nanobeads, micro- or nanocapsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Nanotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
AT98934690T 1997-07-24 1998-07-23 Verfahren zum nachweis eines fibringerinnsels ATE488253T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/AU1997/000467 WO1999004826A1 (en) 1997-07-24 1997-07-24 Method for detection of fibrin clots
PCT/AU1998/000582 WO1999004827A1 (en) 1997-07-24 1998-07-23 Method for detection of fibrin clots

Publications (1)

Publication Number Publication Date
ATE488253T1 true ATE488253T1 (de) 2010-12-15

Family

ID=3764343

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98934690T ATE488253T1 (de) 1997-07-24 1998-07-23 Verfahren zum nachweis eines fibringerinnsels

Country Status (8)

Country Link
US (1) US6977068B1 (de)
EP (1) EP1027080B1 (de)
JP (1) JP3943330B2 (de)
AT (1) ATE488253T1 (de)
AU (2) AU3532197A (de)
CA (1) CA2297399C (de)
DE (1) DE69842003D1 (de)
WO (2) WO1999004826A1 (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999004826A1 (en) * 1997-07-24 1999-02-04 The Australian National University Method for detection of fibrin clots
AU5218500A (en) * 1999-06-22 2001-01-09 Aventis Research & Technologies Gmbh & Co. Kg Stable, radioactively marked nanoparticles, method for the production and utilization thereof
AU2001275078A1 (en) * 2000-06-01 2001-12-11 The Board Of Regents For Oklahoma State University Bioconjugates of nanoparticles as radiopharmaceuticals
AU2006243805B2 (en) * 2005-04-29 2012-02-02 The Australian National University A method of forming an injectable radioactive composition of a carbon encapsulated radioactive particulate
CN101198360B (zh) * 2005-04-29 2010-12-08 澳大利亚国立大学 形成碳包覆的放射性颗粒的可注射放射性组合物的方法
AU2006200755B2 (en) * 2005-07-11 2011-02-10 Cyclomedica Australia Pty Limited Improved process for the production of a radioactive aerosol
US9283291B2 (en) 2008-04-24 2016-03-15 The Australian National University Methods for radiolabeling macromolecules
EP2282781B1 (de) * 2008-04-24 2018-09-05 The Australian National University Verfahren zur radioaktiven markierung von synthetischen polymeren
DE102009015792A1 (de) * 2009-03-23 2010-09-30 Technische Universität Dresden Mittel für die Diagnose der Lungenfunktion mittels Positronen-Emissions-Tomographie
GB0922497D0 (en) * 2009-12-23 2010-02-03 Hammersmith Imanet Ltd Preparation and use of 68GA labelled particles
BR112013013544B1 (pt) 2010-12-01 2020-09-29 The Australian National University Uso de um oligossacarídeo polianiônico na fabricação de um medicamento para o tratamento de sepse
EP4101399B1 (de) 2011-08-05 2025-04-09 Route 92 Medical, Inc. System zur behandlung eines akuten ischämischen schlaganfalls
US10779855B2 (en) 2011-08-05 2020-09-22 Route 92 Medical, Inc. Methods and systems for treatment of acute ischemic stroke
US9265512B2 (en) 2013-12-23 2016-02-23 Silk Road Medical, Inc. Transcarotid neurovascular catheter
US11065019B1 (en) 2015-02-04 2021-07-20 Route 92 Medical, Inc. Aspiration catheter systems and methods of use
HK1247141A1 (zh) 2015-02-04 2018-09-21 92号医疗公司 快速抽吸血栓清除系统和方法
WO2017019563A1 (en) 2015-07-24 2017-02-02 Route 92 Medical, Inc. Anchoring delivery system and methods
US10716915B2 (en) 2015-11-23 2020-07-21 Mivi Neuroscience, Inc. Catheter systems for applying effective suction in remote vessels and thrombectomy procedures facilitated by catheter systems
EP3419528B1 (de) 2016-02-24 2023-06-07 Incept, LLC Neurovaskulärer katheter mit erhöhter flexibilität
CN110381855B (zh) 2017-01-06 2023-07-04 因赛普特有限责任公司 用于动脉瘤治疗装置的抗血栓涂层
EP3568186B1 (de) 2017-01-10 2022-09-14 Route 92 Medical, Inc. Aspirationskathetersysteme
CN110461401B (zh) 2017-01-20 2022-06-07 92号医疗公司 单操作者颅内医疗装置输送系统和使用方法
WO2019212984A1 (en) 2018-05-01 2019-11-07 Imperative Care, Inc. Devices and methods for removing obstructive material from an intravascular site
US11395665B2 (en) 2018-05-01 2022-07-26 Incept, Llc Devices and methods for removing obstructive material, from an intravascular site
JP7616642B2 (ja) 2018-05-17 2025-01-17 ルート９２メディカル・インコーポレイテッド 吸引カテーテルシステム及び使用方法
WO2020010310A1 (en) 2018-07-06 2020-01-09 Imperative Care, Inc. Sealed neurovascular extendable catheter
US11471582B2 (en) 2018-07-06 2022-10-18 Incept, Llc Vacuum transfer tool for extendable catheter
US11766539B2 (en) 2019-03-29 2023-09-26 Incept, Llc Enhanced flexibility neurovascular catheter
WO2021076642A1 (en) 2019-10-15 2021-04-22 Imperative Care, Inc. Systems and methods for multivariate stroke detection
WO2021127004A1 (en) 2019-12-18 2021-06-24 Imperative Care, Inc. Methods and systems for treating venous thromboembolic disease
US20210315598A1 (en) 2019-12-18 2021-10-14 Imperative Care, Inc. Methods of placing large bore aspiration catheters
US11638637B2 (en) 2019-12-18 2023-05-02 Imperative Care, Inc. Method of removing embolic material with thrombus engagement tool
JP7794751B2 (ja) 2020-03-10 2026-01-06 インパラティブ、ケア、インク． 可撓性を増強した神経血管カテーテル
US11207497B1 (en) 2020-08-11 2021-12-28 Imperative Care, Inc. Catheter with enhanced tensile strength
EP4225167A4 (de) 2020-10-09 2024-10-09 Route 92 Medical, Inc. Aspirationskathetersysteme und verfahren zur verwendung
US12376928B2 (en) 2021-08-12 2025-08-05 Imperative Care, Inc. Catheter drive system for supra-aortic access
USD1077996S1 (en) 2021-10-18 2025-06-03 Imperative Care, Inc. Inline fluid filter

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1243784A (en) * 1984-10-04 1988-10-25 William M. Burch Radionuclide metallic vapour
US5217705A (en) * 1987-09-25 1993-06-08 Neorx Corporation Method of diagnosing blood clots using fibrin-binding proteins
US5330768A (en) * 1991-07-05 1994-07-19 Massachusetts Institute Of Technology Controlled drug delivery using polymer/pluronic blends
US5248498A (en) * 1991-08-19 1993-09-28 Mallinckrodt Medical, Inc. Fullerene compositions for magnetic resonance spectroscopy and imaging
GB9203037D0 (en) * 1992-02-11 1992-03-25 Salutar Inc Contrast agents
JPH08502752A (ja) * 1992-10-27 1996-03-26 メルク エンド カンパニー インコーポレーテッド 抗炎症剤及び抗変性剤としての新規の置換アゼチジノン
AU686861B2 (en) * 1994-09-21 1998-02-12 Allrad No. 28 Pty Ltd A precipitator
DE19506188C2 (de) * 1995-02-22 2003-03-06 Miladin Lazarov Implantat und dessen Verwendung
US5640705A (en) * 1996-01-16 1997-06-17 Koruga; Djuro L. Method of containing radiation using fullerene molecules
WO1999004826A1 (en) * 1997-07-24 1999-02-04 The Australian National University Method for detection of fibrin clots

Also Published As

Publication number Publication date
CA2297399C (en) 2007-07-03
EP1027080A4 (de) 2004-07-14
AU3532197A (en) 1999-02-16
US6977068B1 (en) 2005-12-20
JP2001510812A (ja) 2001-08-07
AU744489B2 (en) 2002-02-28
HK1027041A1 (en) 2001-01-05
JP3943330B2 (ja) 2007-07-11
WO1999004827A1 (en) 1999-02-04
AU8425998A (en) 1999-02-16
EP1027080B1 (de) 2010-11-17
DE69842003D1 (de) 2010-12-30
CA2297399A1 (en) 1999-02-04
WO1999004826A1 (en) 1999-02-04
EP1027080A1 (de) 2000-08-16

Similar Documents

Publication Publication Date Title
ATE488253T1 (de) Verfahren zum nachweis eines fibringerinnsels
DE69017636D1 (de) Detektierbarer Gegenstand zur unterirdischen Anwendung und Verfahren zu seiner Lokalisierung.
ATE373822T1 (de) Verfahren zur detektion von markierstoffen in kohlenwasserstoffen und kohlenwasserstoffgemischen
DE69915926D1 (de) Verfahren und Echographiegerät zur Erfassung von Elastizitätsveränderungen
DE69939495D1 (de) Verfahren und system zum testen von computercodes
DE60021216D1 (de) Vorrichtung zur Wiedergabe von Musik, Verfahren zur Taktierungsanalyse und Speichermedium
DE69701314D1 (de) Schlauch und verfahren zur entdeckung von abnutzung
DE59805321D1 (de) Verfahren und anordnung zum erkennen von verteilinformationen
ATE225039T1 (de) Volumenunabhängiger diagnostischer testträger und verfahren zur bestimmung von analyten mit dessen hilfe
ATE225937T1 (de) Diagnostischer testträger mit mehrschichtigem testfeld und verfahren zur bestimmung von analyten mit dessen hilfe
DE69710523D1 (de) Verfahren und Vorrichtung zum Detektieren von Eisenbahnaktivität
DE69826583D1 (de) Vorrichtung und Verfahren zum Erreichen von klinischen wichtigen Analytverhältnissen
DE60122786D1 (de) System und verfahren zum kommentieren von medizinischen patienteninformationen
DE69534301D1 (de) Kulturmedium und vorrichtung zum nachweis und zur quantifizierung von enterobakteriaceae
DE69520004D1 (de) Verfahren zum feststellen und/oder zum identifizieren von mikrobenkolonien
DE69806802D1 (de) Verfahren zur unterscheidung von erythroblasten
DE69804251D1 (de) Verfahren und vorrichtung zum zementieren von futterrohren in bohrlöchern
DE69709087D1 (de) Verfahren zum nachweis und zur identifizierung von mikroorganismen
DE69821121D1 (de) Verfahren und anordnung zur blutdruckmessung
DE60023779D1 (de) Vorrichtung und Verfahren zur Überblendungsdetektion und Überblendungsinformationscodierung
DE3575621D1 (de) Verfahren und anordnung zum kennzeichnen und erkennen von gegenstaenden.
DE69203640D1 (de) Unsichtbare Kennzeichen für Petroleum, Verfahren zur Markierung und Verfahren zum Nachweisen.
ATE343788T1 (de) Verfahren zum simultanen nachweis von beiden gliedern eines bindungspaares
DE69834493D1 (de) Verfahren und gerät zum nachweis und zur zählung von mikroorganismen
DE69927871D1 (de) Vorrichtung und Verfahren zur Unterscheidung von Erythrozyten in Urin

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties